MEMORY PHENOTYPE IN ALLOGENEIC ANTI-BCMA CAR-T CELL THERAPY (P-BCMA-ALLO1) CORRELATES WITH IN VIVO TUMOR CONTROL

被引：0

作者：

Tseng, Hubert ^{[1
]}

Zhang, Yan ^{[1
]}

Cranert, Stacey ^{[1
]}

Richter, Maximilian ^{[1
]}

Marquez, Karl ^{[1
]}

Qiu, Jing ^{[1
]}

Cho, Benjamin ^{[1
]}

Tan, Yening ^{[1
]}

Tong, Min ^{[1
]}

Domingo, Christine ^{[1
]}

Weiss, Leslie ^{[1
]}

Argus, Elvira ^{[1
]}

Sparks, Jessica ^{[1
]}

Ostertag, Eric ^{[1
]}

Coronella, Julia ^{[1
]}

Shedlock, Devon ^{[1
]}

机构：

[1] Poseida Therapeut, San Diego, CA USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷

关键词：

D O I：

10.1136/jitc-2021-SITC2021.147

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

147

引用

页码：A155 / A155

页数：1

共 50 条

[1] Memory Phenotype in Allogeneic Anti-BCMA CAR-T Cell Therapy (P-BCMA-ALLO1) Correlates with In Vivo Tumor Control
Tseng, Hubert
Zhang, Yan
Cranert, Stacey A.
Richter, Maximilian
Marquez, Karl
Qiu, Jing
Cho, Benjamin
Tan, Yening
Tong, Min
Domingo, Christine
Weiss, Leslie
Argus, Elvira
Sparks, Jessica
Ostertag, Erica M.
Coronella, Julia
Sheldlock, Devon J.
BLOOD, 2021, 138
[2] P-BCMA-ALLO1-a nonviral, allogeneic anti-BCMA CAR-T therapy with potent antitumor function for the treatment of multiple myeloma
Richter, Maximilian
Cranert, Stacey
Tan, Yening
Tong, Min
Domingo, Christine
Argus, Elvira
Ibitokou, Samad
Smith, Jenessa
Martin, Christopher
Wang, Xinxin
Barnett, Burton
Ostertag, Eric
Coronella, Julia
Shedlock, Devon
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
[3] Single cell Dissection of Resistance to anti-BCMA CAR-T cell Therapy
Ledergor, Guy
McCarthy, Elizabeth
Shah, Nina
Wong, Sandy
Chang, Hewitt
Fan, Frances
Shao, Evans
Gray, Lissa
Cheung, Alexander
Kwek, Serena
Bylsma, Sophia
Del Favero, Samuel
Wustrack, Rosanna
Spitzer, Matthew
Wolf, Jeffrey
Martin, Thomas
Ye, Jimmie
Fong, Lawrence
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E25 - E26
[4] Manufacture of an Allogeneic CAR-T Stem Cell Memory Product Candidate for Multiple Myeloma, P-Bcma-ALLO1, Is Robust, Reproducible and Highly Scalable
Cranert, Stacey A.
Richter, Maximilian
Tong, Min
Weiss, Leslie
Tan, Yening
Ostertag, Eric M.
Coronella, Julia
Shedlock, Devon J.
BLOOD, 2019, 134
[5] A Phase 1 Study of P-BCMA-ALLO1, a Non-viral, Allogeneic BCMA Directed CAR-T in Relapsed/Refractory Multiple Myeloma (RRMM)
Dholaria, Bhagirathbhai
Kocoglu, Mehmet
Andrew, Kin
Ramakrishnan, Aravind
Shune, Leyla
Ganguly, Siddhartha
Cruz, Jose
Strouse, Christopher
Malek, Ehsan
Faber, Edward
McArthur, Katherine
McCaigue, Joanne
DePrimo, Sam
Martin, Chris
Haag, Sabrina
Eskew, Jeff
Namini, Hamid
Christie, Ellen
Belani, Rajesh
Rizvi, Syed
Cranert, Stacey
Coronella, Julia
Shedlock, Devon
Costello, Caitlin
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S3 - S3
[6] P-BCMA-ALLO1-A Fully Allogeneic Stem Cell Memory T Cell (TSCM) CAR-T Therapy Targeting BCMA for the Treatment of Multiple Myeloma Shows Potent Anti-Tumor Activity
Richter, Maximilian
Cranert, Stacey
Patil, Deepak
Zhang, Yan
Tan, Yening
Tong, Min
Domingo, Christine
Weiss, Leslie
Marquez, Karl
Sparks, Jessica
Argus, Elvira
Martin, Christopher
Ostertag, Eric
Jain, Sumiti
Coronella, Julia
Shedlock, Devon
MOLECULAR THERAPY, 2021, 29 (04) : 382 - 383
[7] GUILLAIN-BARRE SYNDROME FOLLOWING ANTI-BCMA CAR-T CELL THERAPY
Rutenberg, David
CHEST, 2023, 164 (04) : 6183A - 6184A
[8] Incidence of Parkinsonism As a Complication of Anti-BCMA CAR-T Cell Therapy in Multiple Myeloma
Singh, Vaishnavi
Master, Samip
BLOOD, 2023, 142
[9] Anti-BCMA CAR-T cells therapy for a patient with extremely high membrane BCMA expression: a case report
Li, Dan
Que, Yimei
Ding, Shengnan
Hu, Guang
Wang, Wen
Mao, Xia
Wang, Ying
Li, Chunrui
Huang, Liang
Zhou, Jianfeng
Zhang, Wei
Xiao, Min
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (09)
[10] Anti-BCMA CAR T-Cell Therapy in Multiple Myeloma
Quintas-Cardama, Alfonso
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (03):

← 1 2 3 4 5 →